首页> 外文期刊>Transactions of the American Ophthalmological Society. >Studies of intrastromal corneal ring segments for the correction of low to moderate myopic refractive errors.
【24h】

Studies of intrastromal corneal ring segments for the correction of low to moderate myopic refractive errors.

机译:基质内角膜环节段的研究,用于矫正低至中度近视屈光不正。

获取原文
       

摘要

PURPOSE: Intrastromal corneal ring segments (ICRS) were investigated for safety and reliability in the correction of low to moderate myopic refractive errors. METHODS: Initially, 74 patients with spherical equivalent refractive errors between -1.00 and -4.25 diopters (D) received the ICRS in 1 eye. After 6 months, 51 of these patients received the ICRS in the contralateral eye. The total number of eyes investigated was 125. The outcome measures were uncorrected and best-corrected visual acuity, predictability and stability of the refraction, refractive astigmatism, contrast sensitivity, and endothelial cell morphology. RESULTS: The 89 eyes with 12-month follow-up showed significant improvement with uncorrected visual acuities of 20/16 or better in 37%, 20/20 or better in 62%, and 20/40 or better in 97%. Cycloplegic refraction spherical equivalents showed that 68% of the eyes were within +/- 0.50 D and 90% within +/- 1.00 D of the intended correction. Refractive stability was present by 3 months after the surgery. Only 1 patients had a loss greater than 2 lines or 10 letters of best spectacle-corrected visual acuity, but the patient's acuity was 20/20. Refractive cylinder, contrast sensitivity, and endothelial cell morphology were not adversely affected. The ICRS was removed from the eyes of 6 patients. Three removals were prompted by glare and double images occurring at night; 3 were for nonmedical reasons. All patients returned to within +/- 1.00 D of their preoperative refractive spherical equivalent, and no patients lost more than 1 line of best corrected visual acuity by 3 months after ICRS removal. CONCLUSION: The ICRS safely and reliably corrects myopic refractive errors between -1.00 and -4.50 D.
机译:目的:研究了角膜内角膜环节段(ICRS)在校正中低度近视屈光不正中的安全性和可靠性。方法:最初,74眼等效屈光度在-1.00到-4.25屈光度(D)之间的患者接受了1眼ICRS。 6个月后,其中51例患者的对侧眼接受了ICRS。研究的眼睛总数为125。结果指标未经矫正和最佳矫正的视力,验光的可预测性和稳定性,屈光散光,对比敏感度和内皮细胞形态。结果:随访12个月的89眼表现出明显的改善,未矫正视力为37%,20/16或更高,62%为20/20或97%为20/40或更高。眼周屈光度等效球镜显示,有68%的眼睛在预期矫正的+/- 0.50 D之内,有90%的眼睛在+/- 1.00 D之内。术后3个月出现屈光稳定。只有1例患者的视力丧失大于2行或10个字母的最佳眼镜矫正视力,但患者的视力为20/20。屈光柱,对比敏感度和内皮细胞形态均未受到不利影响。从6例患者的眼睛中取出了ICRS。夜间眩光和双重图像提示进行了三次清除; 3出于非医学原因。所有患者均恢复至术前屈光度当量+/- 1.00 D之内,并且在移除ICRS后的3个月内,没有患者损失超过1行的最佳矫正视力。结论:ICRS安全可靠地校正了-1.00至-4.50 D之间的近视屈光不正。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号